Jim Wu is the founder of Ark Biosciences. Ark Biosciences has raised $230M in total funding. Latest round: Series A. Based in Shanghai, China.
Jim Wu is the Founder and CEO of Ark Biosciences, a clinical-stage biopharmaceutical company based in Shanghai, China. The company focuses on developing small molecule therapeutics for respiratory viral infections and viral hepatitis. Ark Biosciences has raised funding from investors including TPG, Decheng Capital, Loayal Valley Capital, Qiming Venture Partners, Morningside Venture, and TF Capital.
Full founder directory · Investor directory · Company funding database · Fundraising library